Santa Cruz Biotechnology Inc.

Dallas, TX

UEI
NLN6VWMFNB29
CAGE
1FAA0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10410 Finnell St, Dallas, TX 75220, USA
Website
scbt.com
Founded
1991
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$5
FY2024 $0
FY2023 $6,000

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Santa Cruz Biotechnology Inc. is a self-certified small disadvantaged business that provides a wide range of biological and scientific products to the U.S. federal government. Registered to receive federal awards since 2002, the company is structured as a corporate entity and is classified as a manufacturer of goods. Santa Cruz Biotechnology specializes in the production and supply of research-grade antibodies, biochemicals, and laboratory equipment, serving the needs of scientific and medical research communities.

Recent federal contract awards to Santa Cruz Biotechnology demonstrate the company's role in supplying specialized chemicals and biological materials to government agencies. In August 2023, the National Oceanic and Atmospheric Administration (NOAA) awarded the company a $6,000 purchase order for heptadecafluorooctanesulfonic acid (PFOS), likely to support environmental monitoring programs. This contract was set aside for small businesses. Earlier, in January 2020, the Administration for Children and Families issued an $11,933 purchase order to the company, although the specific products were not detailed. These awards highlight Santa Cruz Biotechnology's capability to provide highly specific chemical compounds and research materials to diverse federal agencies engaged in scientific and environmental research.

Santa Cruz Biotechnology holds a significant Blanket Purchase Agreement (BPA) with the Office of Logistics and Acquisition Operations, a civilian agency. This single-award BPA, valued at $100,000,000, was awarded in June 2024 and extends through June 2025. The agreement covers a comprehensive range of products including biological materials, media, RNA interference products, proteins, CRISPR tools, antibodies, chemicals, glassware, pharmacy supplies, sanitation supplies, medical and veterinary surgical supplies, and scientific equipment and instruments. This broad-scope BPA underscores Santa Cruz Biotechnology's position as a key supplier of diverse research and laboratory materials to the federal government, providing a streamlined procurement process for a wide array of scientific and medical supplies.

Quick answers

Is Santa Cruz Biotechnology Inc. registered in SAM.gov?

Yes. Santa Cruz Biotechnology Inc.'s SAM.gov registration is active through November 18, 2026.

How much has Santa Cruz Biotechnology Inc. received in federal contracts?

Federal contracts obligated $5,995 to Santa Cruz Biotechnology Inc. in fiscal years 2023 through 2027.

What is Santa Cruz Biotechnology Inc.'s most recent federal award?

Santa Cruz Biotechnology Inc.'s most recent federal contract award is Heptadecafluorooctanesulfonic acid (pfos) (1305M223PNCNS0322), from National Oceanic and Atmospheric Administration, on August 31, 2023.

On GovTribe

See Santa Cruz Biotechnology Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors